University Hospital Ulm
University Hospital Ulm
Ulm, Germany17 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2 | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 3 | 2026-10-06 | NCT04628026 | |
| A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, primary sclerosing cholangitis | Active, not recruiting | Phase 2 | 2026-10-01 | NCT05627362 | |
| Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair | Colorectal Neoplasms, Hereditary Nonpolyposis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA repair disease, Digestive System Diseases, Digestive System Neoplasms, Lynch syndrome, Neoplasms by Site, Nutritional and Metabolic Diseases, colon adenocarcinoma, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, hereditary disease, hereditary neoplastic syndrome, intestinal disorder, metabolic disease, neoplasm | Active, not recruiting | Phase 3 | 2026-10-01 | NCT02912559 | |
| The DefiPace Study | Post-operative Atrial Fibrillation POAF | Recruiting | Not stated | 2026-07-30 | NCT04804748 | |
| Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors | Female Urogenital Diseases and Pregnancy Complications, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Nonseminomatous germ cell tumor, Pregnancy Complications, Neoplastic, Urogenital Diseases, adenocarcinoma, carcinoma, choriocarcinoma, epithelial neoplasm, extragonadal seminoma, germinoma, malignant germ cell tumor, mesonephric neoplasm, mixed germ cell tumor, neoplasm, nongerminomatous germ cell tumor, pregnancy disorder, seminoma, teratoma, trophoblastic neoplasm, yolk sac tumor | Active, not recruiting | Phase 3 | 2026-06-16 | NCT02375204 | |
| Efficacy and Safety of Carfilzomib in Combination With Ibrutinib vs Ibrutinib in Waldenström's Macroglobulinemia | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Waldenstrom macroglobulinemia, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2026-05-12 | NCT04263480 | |
| PrEventing PostoPERative Pulmonary Complications by Establishing a MachINe-learning assisTed Approach | Postoperative Pulmonary Complications | Recruiting | Not stated | 2026-05-08 | NCT05789953 | |
| Copanlisib and Rituximab in Marginal Zone Lymphoma Patients | B-cell neoplasm, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, marginal zone lymphoma, neoplasm | Active, not recruiting | Phase 2 | 2026-05-06 | NCT03474744 | |
| Obinutuzumab in Marginal Zone Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, marginal zone lymphoma, neoplasm | Active, not recruiting | Phase 2 | 2026-05-06 | NCT03322865 | |
| Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Waldenstrom macroglobulinemia, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 2 | 2026-05-05 | NCT05099471 | |
| Magnetic Resonance Imaging in Metabolic Diseases | Nutritional and Metabolic Diseases, metabolic disease | Recruiting | Not stated | 2026-02-13 | NCT06709846 | |
| A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Active, not recruiting | Phase 2 | 2025-12-15 | NCT05611671 | |
| Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19 | Angina Pectoris, COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Left Ventricle Remodeling, Microvascular Angina, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, Vascular Remodeling, Ventricular Dysfunction, Ventricular Dysfunction, Left, Ventricular Remodeling, cardiomyopathy, cardiovascular disorder, heart disorder, long COVID-19, lung disorder, myocardial ischemia, myocarditis, pericarditis, pneumonia, respiratory system disorder, respiratory tract infectious disorder, vascular disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 3 | 2025-12-09 | NCT05619653 | |
| Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Recruiting | Phase 3 | 2025-09-25 | NCT06479135 | |
| Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk | cardiovascular disorder, heart disorder, heart valve disorder, mitral valve insufficiency | Recruiting | Not applicable | 2025-09-15 | NCT04029363 | |
| Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis | Mandibular Reconstruction; Segmental Mandibular Defects | Recruiting | Not stated | 2025-09-04 | NCT04098146 | |
| Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA) | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 2 | 2025-08-06 | NCT05690048 |